(Q108396468)

1

0 references

Mengli Yang

2

0 references

Zilei Duan

3

0 references

Zhiyi Liao

4

0 references

Lei Liu

5

0 references

Ruomei Cheng

6

0 references

Mingqian Fang

7

0 references

Gan Wang

8

0 references

Hongqi Liu

9

0 references

Jingwen Xu

10

0 references

Peter M Kamau

11

0 references

Zhiye Zhang

12

0 references

Lian Yang

13

0 references

Xudong Zhao

14

0 references

Xiaozhong Peng

15

0 references

Ren Lai

Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells

16

0 references

publication date

23 October 2020

0 references

cites work

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Crystal structure of the ectodomain of human transferrin receptor

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Regulation of iron transport and the role of transferrin

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Balancing acts: molecular control of mammalian iron metabolism

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Binding site on the transferrin receptor for the parvovirus capsid and effects of altered affinity on cell uptake and infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus.

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Residues in the apical domain of the feline and canine transferrin receptors control host-specific binding and cell infection of canine and feline parvoviruses.

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Natural resistance-associated macrophage protein is a cellular receptor for sindbis virus in both insect and mammalian hosts

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

The long history of iron in the Universe and in health and disease

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Identification of transferrin receptor 1 as a hepatitis C virus entry factor

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Mouse mammary tumor virus uses mouse but not human transferrin receptor 1 to reach a low pH compartment and infect cells

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

New World Arenavirus Biology.

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Two mink parvoviruses use different cellular receptors for entry into CRFK cells

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Angiotensin-converting enzyme 2 protects from severe acute lung failure

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

A pneumonia outbreak associated with a new coronavirus of probable bat origin

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

A Novel Coronavirus from Patients with Pneumonia in China, 2019

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Structure analysis of the receptor binding of 2019-nCoV

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Clinical Characteristics of Coronavirus Disease 2019 in China

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Structural basis of receptor recognition by SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

3 September 2021

COVID-19 and the Heart

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Current status of potential therapeutic candidates for the COVID-19 crisis

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

3 September 2021

1 reference

https://api.crossref.org/works/10.1101/2020.10.23.350348